Patient | Age/ sex | Duration of MG(y) | Duration of dysphagia (months) | Initial symptomatology | Present symptomatology1-150 |
---|---|---|---|---|---|
1 | 40/F | 1 | 3 | Ocular | Ocular+bulbar |
2 | 46/M | 5/12 | 5 | Bulbar | Bulbar |
3 | 36/M | 2/12 | 2 | Ocular+bulbar | Ocular+bulbar |
4 | 70/F | 1 | 24 | Generalised | Generalised |
5 | 34/F | 15 | 0.5 | Ocular+bulbar | Generalised |
6 | 53/M | 6/12 | 6 | Ocular+bulbar | Ocular+bulbar |
7 | 55/M | 1 | 6 | Ocular+bulbar | Ocular+bulbar |
8 | 52/M | 5 | 1 | Ocular+bulbar | generalised |
9 | 76/M | 3 | 2 | Ocular | Ocular+bulbar |
10 | 32/F | 4 | 3 | Generalised | Generalised |
11 | 48/F | 1 | 0.5 | Generalised | Generalised |
12 | 28/F | 1 | 2 | Bulbar | Bulbar |
13 | 53/M | 9 | 12 | Generalised | Generalised |
14 | 30/F | 10 | 3 | Ocular | Generalised |
15 | 34/F | 12 | 24 | Bulbar | Bulbar |
16 | 50/M | 3/12 | None | Ocular | Ocular+bulbar |
17 | 27/F | 5 | None | Generalised | Generalised |
18 | 69/M | 1.5 | None | ocular | Generalised |
19 | 32/F | 3 | None | Generalised | Generalised |
20 | 25/F | 1 | None | Ocular | Generalised |
21 | 49/F | 1 | None | Ocular | Ocular+bulbar |
22 | 42/F | 12 | None | Ocular+bulbar | Ocular+bulbar |
23 | 39/M | 2 | None | Generalised | Generalised |
24 | 47/M | 8 | None | Ocular | Generalised |
25 | 39/M | 7/12 | None | Generalised | Generalised |
↵1-150 Clinical features of patients with myasthenia gravis; either dysphagic or not at the time of the investigation; none=without dysphagia.